Equaly sa
" Novel methods to prevent and treat Covid-19 viral infection by inhibiting virus entry "
Funding: not disclosed 

Equaly sa
" A novel strategy to prevent virus entry through the ACE2R A novel strategy for preventive vaccination to Covid-19 Monoclonal antibodies targeting the ACE2R are used to block virus entry. Vaccines are prepared eliciting a Th1response together with cytotoxic T cells. "
Funding: private
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aesculape CRO Belgium BV
" Treatment of COVID 19 complications with antibodies "
Funding: partly public partly private
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it. 0492 735931

EXO Biologics
" EXO Biologics plans to extend its research and development program towards the COVID-19 crisis by using its unique and disruptive technology based on Extracellular Vesicles. These nanometer size particles are gaining momentum in the scientific community as potential alternatives to stem cell and biologic drugs therapies in the fields of immunology, neurology, oncology, cardiology, gastroenterology among others. EXO Biologics has 12 years of experience in cell-based regenerative medicine and 8 years of experience in Extracellular Vesicles. Our advancements in research will play an important role for our company mission to provide affordable and accessible therapies to patients with unmet medical needs. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

DELTRIAN
" Deltrian has developed four complete production lines for surgical masks (production and packaging) which will be operational in Fleurus from the end of May 2020. Deltrian will produce 160 surgical masks per minute following a work divided into two breaks. That is a total of 60 million masks per year. A shift to three breaks could even increase production to 90 million masks per year. In response to a request from the federal government and together with the company Sioen (Ardooie, West Flanders), Deltrian will also have the task of producing 20 million filters that will be used to improve the quality of cloth masks that will be compulsory to wear on public transport from 4 May 2020. This is part of a desire to repatriate certain know-how to Wallonia and is an integral part of the Region's reindustrialisation strategy. "
Contact: http://www.deltrian.com/

3D-Side S.A.
" "- 3D printing of swabs in SLS - 3D printing of valves - 3D printing of connectors for respiratory systems - Advice on guidelines on the manufacturing and post processing of such devices." "
Contact: Khanh TRAN DUY This email address is being protected from spambots. You need JavaScript enabled to view it.

Covartim
"In the global effort to help the healthcare professionals in the fight against the Covid pandemic, we are providing documents to help manufacturers that are not familiar with medical devices to properly document their work to help them in their product development and achieving compliance. These templates are derived from our technical file documentation and include some reference to guidances (mostly applicable in Belgium) for devices and accessories to answer to hospital products shortage."
Contact : Covartim www.covartim.be This email address is being protected from spambots. You need JavaScript enabled to view it.

BECARV SA
" BECARV supplies and install solution and equipement for labs, such as modular biosafety cabinets, air purifier for containment of a room, filter units, etc "
Contact: www.becarv.be Michaël Jeanty This email address is being protected from spambots. You need JavaScript enabled to view it.

Coris BioConcept
" Early February we started the development of a rapid antigen detection assay for SARS-CoV-2. The COVID-19 Ag Respi-Strip Assay was validated in three University hospital laboratories and registered (CE mark) by end of March. The test is designed as a first line triage assay to be used for rapid (15 minutes) detection of SARS-CoV-2 on symptomatic patients. We are currently developing a serological assay that targets the immune response against several antigens of the virus. "
Publication References: https://jcm.asm.org/content/jcm/early/2020/05/11/JCM.00977-20.full.pdf https://www.frontiersin.org/articles/10.3389/fmed.2020.00225/full?utm_campaign=ba-cov-sci-fmed-respi-strip&utm_medium=cvlp&utm_source=fweb
Contact: https://www.corisbio.com/Products/Human-Field/Covid-19.php product-sales: This email address is being protected from spambots. You need JavaScript enabled to view it. science-R&D: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aseptic Technologies SA
" Table-top equipment for FFP2 mask decontamination by means of UV-C, developed jointly by Lasea s.a. and Aseptic Technologies s.a. Allows re-use of FFP2 masks up to 5 times (under validation process) "
Contact: Patrick Baleriaux CEO Aseptic Technologies s.a This email address is being protected from spambots. You need JavaScript enabled to view it.

Malcourant Mécanique
" We have developed a semi-automatic machine to weld polyethylene sheets in order to make the COVID-19 protective mask envelope. This development has been carried out entirely in-house, study - manufacture - assembly. We called the company ICS to improve the working conditions for the welding jaws. "
Contact: malcourant-mecanique.be incosol4u.com

GSK - Royal Academy of Medicine of Belgium
" Support covid international: https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/ Support covid en Belgique: https://be.gsk.com/media/915368/cp-gsk-contributions-majeures-de-gsk-a-la-lutte-contre-le-covid-19.pdf NA NA "
Funding: NA
Contact: Philippe Denoel - This email address is being protected from spambots. You need JavaScript enabled to view it.

Any-Shape
" Production of nasopharyngeal swabs using 3D printing "
Contact: Roger Cocle CEO This email address is being protected from spambots. You need JavaScript enabled to view it.

Innovative Coating Solutions
" Within the framework of mask making, ICS has been contacted by the company Malcourant (GBLX) which developed special machines to produce polymer (Polyethylene) based masks. The process requires thermal welding of polymer foils. That process happens around 170°C, in between two pressed and heated jaws. Unfortunately, adhesion of the polyethylene on either Al or Cu jaw is observed. ICS develops special coatings and made available a carbon based coating that prevents the adhesion on the jaw, but allow also multiple cycles of heating/cooling. These coatings have been successfully applied on the aluminium and copper prototypes. They exhibit very good adhesion, and prevent the polyethylene sticking on the jaws even after a large number of cycles. No delamination has been observed so far. "
Contact: Stéphane Lucas, Innovative Coating Solutions, This email address is being protected from spambots. You need JavaScript enabled to view it. Patrick Powis, Malcourant-Mécanique, This email address is being protected from spambots. You need JavaScript enabled to view it.